Correlation Between Engie Brasil and Profarma Distribuidora

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Engie Brasil and Profarma Distribuidora at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Engie Brasil and Profarma Distribuidora into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Engie Brasil Energia and Profarma Distribuidora de, you can compare the effects of market volatilities on Engie Brasil and Profarma Distribuidora and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Engie Brasil with a short position of Profarma Distribuidora. Check out your portfolio center. Please also check ongoing floating volatility patterns of Engie Brasil and Profarma Distribuidora.

Diversification Opportunities for Engie Brasil and Profarma Distribuidora

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Engie and Profarma is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Engie Brasil Energia and Profarma Distribuidora de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Profarma Distribuidora and Engie Brasil is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Engie Brasil Energia are associated (or correlated) with Profarma Distribuidora. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Profarma Distribuidora has no effect on the direction of Engie Brasil i.e., Engie Brasil and Profarma Distribuidora go up and down completely randomly.

Pair Corralation between Engie Brasil and Profarma Distribuidora

Assuming the 90 days trading horizon Engie Brasil is expected to generate 7.57 times less return on investment than Profarma Distribuidora. But when comparing it to its historical volatility, Engie Brasil Energia is 2.53 times less risky than Profarma Distribuidora. It trades about 0.02 of its potential returns per unit of risk. Profarma Distribuidora de is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  295.00  in Profarma Distribuidora de on August 30, 2024 and sell it today you would earn a total of  412.00  from holding Profarma Distribuidora de or generate 139.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.8%
ValuesDaily Returns

Engie Brasil Energia  vs.  Profarma Distribuidora de

 Performance 
       Timeline  
Engie Brasil Energia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Engie Brasil Energia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Profarma Distribuidora 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Profarma Distribuidora de are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Profarma Distribuidora unveiled solid returns over the last few months and may actually be approaching a breakup point.

Engie Brasil and Profarma Distribuidora Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Engie Brasil and Profarma Distribuidora

The main advantage of trading using opposite Engie Brasil and Profarma Distribuidora positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Engie Brasil position performs unexpectedly, Profarma Distribuidora can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profarma Distribuidora will offset losses from the drop in Profarma Distribuidora's long position.
The idea behind Engie Brasil Energia and Profarma Distribuidora de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance